This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Glucagon-like peptide-1 (GLP-1) analogues
GLP1ANA
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
429209 |
1. Apply sex-specific ruleNone |
429209 |
2. Check conditionsNone |
429209 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
1 out of 7 registries used, show all original rules. |
21626 |
4. Check minimum number of events
Min. number of events
3
|
21626 |
5. Include endpointsNone |
21626 |
6. Filter based on genotype QC (FinnGen only) |
20866 |
Control definitions (FinnGen only)
Control exclude
DIAB_MED_OTHER
Extra metadata
First used in FinnGen datafreeze
DF2
Similar endpoints
↥List of similar endpoints to
Glucagon-like peptide-1 (GLP-1) analogues
based on the number of shared cases.
Broader endpoints:
- Other (not insulin) diabetes medications
- Diabetes medication
- Type 2 diabetes
- Diabetes mellitus
- Endocrine, nutritional and metabolic diseases
Narrower endpoints:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 20866 | 9112 | 11754 |
| Unadjusted period prevalence (%) | 5.37 | 3.96 | 6.46 |
| Median age at first event (years) | 66.13 | 65.76 | 66.41 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: GLP1ANA – Glucagon-like peptide-1 (GLP-1) analogues
GWS hits: -
Loading Relationships table